The updated guideline addresses rapid advances in pharmacologic management, balancing use of newer, older drugs.

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

Expert panelists share final points of emphasis regarding treatment for CKD. Ryan Haumschild, PharmD, MS, MBA: Dr Nicholas, we’ve talked a lot about halting progression. What more can we do to delay ...

Dr Haumschild drives a conversation regarding CKD treatment in the presence comorbidities such as cardiovascular disease and type 2 diabetes. Ryan Haumschild, PharmD, MS, MBA: It’s very clear that ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Dapagliflozin reduced left ventricular mass index early into treatment in patients with nondialysis-dependent CKD, regardless of disease etiology and cardiovascular history. Dapagliflozin reduces left ...

Kidney disease is the third-fastest-growing cause of death globally. Here's why doctors are sounding the alarm. Kidney disease is a serious yet often overlooked condition that affects millions ...

Chronic kidney disease (CKD) has been called an “under-recognized public health crisis,” and is estimated to impact 14% of US adults. CKD patients typically have to undergo regular dialysis treatment ...

The European Renal Association (ERA) kicks off its 61st ERA Congress in Stockholm, Sweden, with a theme of "Rethinking kidney health, transforming kidney care," and a program full of sessions delving ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.